Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1998-10-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM9810046PMID 9767635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.

  1997cited by this paper
• Synthesis and antitumor activity of some analogues of flavone acetic acid.

  1996cited by this paper
• Phenserine and ring C hetero‐analogues: Drug candidates for the treatment of Alzheimer's disease

  1995cited by this paper
• Docking analysis of a series of benzylamino acetylcholinesterase inhibitors with a phthalimide, benzoyl, or indanone moiety.

  1994cited by this paper
• Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates.

  1994cited by this paper
• Benzo-gamma-pyrone analogues of geiparvarin: synthesis and biological evaluation against B16 melanoma cells.

  1993cited by this paper
• Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.

  1992cited by this paper
• Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues.

  1992cited by this paper
• Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein

  1991cited by this paper
• In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.

  1991cited by this paper
• Central cholinergic agents. I. Potent acetylcholinesterase inhibitors, 2-[omega-[N-alkyl-N-(omega-phenyl-alkyl)amino]alkyl]-1H-isoindole- 1,3(2H)-diones, based on a new hypothesis of the enzyme's active site.

  1991cited by this paper
• Xanthone 1,4-dihydropyridine derivatives with a potent selective bradycardic effect.

  1990cited by this paper
• Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.

  1990cited by this paper
• Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives.

  1990cited by this paper
• Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.

  1989cited by this paper
• 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.

  1989cited by this paper
• Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice.

  1988cited by this paper
• (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.

  1988cited by this paper
• A long-lasting cholinesterase inhibitor affecting neural and behavioral processes.

  1987cited by this paper
• Xanthone Analogue of Geiparvarin

  1986cited by this paper
• Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

  1986cited by this paper
• Xanthone analogues of clofibrate / Synthesis and biological evaluation as antagonists of lipolysis in vitro.

  1982cited by this paper
• A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations.

  1975cited by this paper
• -Adrenergic blocking agents of the chromone and xanthone groups.

  1972cited by this paper
• Central nervous system stimulants of the xanthone group.

  1970cited by this paper
• Kinetics of the carbamylation of cholinesterase.

  1968cited by this paper
• A radiometric microassay of acetylcholinesterase.

  1967cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• Carbamylation of acetvlcholinesterase.

  1960cited by this paper

• Xanthones as Neuroprotective Agents: A Comprehensive Review of Their Role in the Prevention and Treatment of Neurodegenerative Diseases.

  2025cites this paper
• Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.

  2022cites this paper
• Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer's disease

  2021cites this paper
• Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies

  2021cites this paper
• Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies.

  2021cites this paper
• Synthesis of 1-hydroxy-3-O-substituted xanthone derivatives and their structure-activity relationship on acetylcholinesterase inhibitory effect

  2021cites this paper
• Recent advances in the synthesis of xanthones and azaxanthones

  2020cites this paper
• Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure–activity relationship and molecular modelling simulations

  2020cites this paper
• Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease

  2019cites this paper
• In silico discovery of noteworthy multi-targeted acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease

  2019cites this paper
• Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory.

  2019cites this paper
• Donepezil Derivatives Targeting Amyloid-β cascade in Alzheimer's Disease.

  2019cites this paper
• Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

  2018cites this paper
• Water‐PEG‐400 Mediated an Efficient One‐Pot Eco‐Friendly Synthesis of Functionalized Isoxazole Substituted Chromeno[2, 3‐ b ]pyridine‐3‐carboxylate Derivatives

  2018cites this paper
• Computational Modeling of Multi-target-Directed Inhibitors Against Alzheimer’s Disease

  2018cites this paper
• Design, synthesis and biological evaluation of 1,3-dihydroxyxanthone derivatives: Effective agents against acetylcholinesterase.

  2017cites this paper
• Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

  2017cites this paper
• Reactions of 3‐Acylchromones with Heterocyclic Ketene Aminals: One‐Pot Synthesis and Phosphatase Inhibitory Activity of Fused Pyridine Derivatives

  2017cites this paper
• Hybrids: a new paradigm to treat Alzheimer’s disease

  2016cites this paper
• Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies.

  2016cites this paper
• Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.

  2016cites this paper
• Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi‐ and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β‐Amyloid (Aβ) Aggregation

  2015cites this paper
• Xanthone and Flavone Derivatives as Potential Dual Agents for Alzheimer's Disease

  2015cites this paper
• Dual Binding Site and Selective Acetylcholinesterase Inhibitors Derived from Integrated Pharmacophore Models and Sequential Virtual Screening

  2014cites this paper
• Synthesis of Flavonoid Derivatives of Cytisine. 3. Synthesis of 7-[2-(Cytisin-12-yl)ethoxy]isoflavones

  2013cites this paper
• Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates.

  2013cites this paper
• Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents

  2013cites this paper
• Bivalent Organophosphorus Compounds—Synthesis and Acetylcholinesterase Inhibitory Activity

  2013cites this paper
• Molecular docking study of 3,6 bis(3'substituted propoxy) and 3,6 bis (5'substituted pentyloxy) xanthone derivatives as PGHS- 2 inhibitors

  2013cites this paper
• Synthesis and evaluation of substituted 4-methyl-2-oxo-2H-chromen-7-yl phenyl carbamates as potent acetylcholinesterase inhibitors and anti- amnestic agents.

  2013cites this paper
• Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment?

  2013cites this paper
• Synthesis of 7-β-(N,N-dialkylamino)ethoxy derivatives of natural isoflavones and 4-aryl-3-[2-hydroxy-4-β-(N,N-dialkylamino) ethoxy]phenylpyrazoles based on them

  2013cites this paper
• Quantitative structure and bioactivity relationship study on human acetylcholinesterase inhibitors.

  2012cites this paper
• Classification of acetylcholinesterase inhibitors and decoys by a support vector machine.

  2012cites this paper
• 2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents.

  2012cites this paper
• Acetylcholinesterase-Inhibiting Activity of Salicylanilide N-Alkylcarbamates and Their Molecular Docking

  2012cites this paper
• Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1).

  2012cites this paper
• Acetyl‐ and Butyryl‐cholinesterase Inhibitory Activities of Mansorins and Mansonones

  2012cites this paper
• The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?

  2012cites this paper
• Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study

  2012cites this paper
• Synthesis of Multi-Functionalized Chromeno[2,3-c]pyrrol-9(2H)-ones: Investigation and Application of Baker―Venkataraman Rearrangement Involved Reactions Catalyzed by 4-(Dimethylamino)pyridine

  2011cites this paper
• Multi-target strategy to address Alzheimer's disease: design, synthesis and biological evaluation of new tacrine-based dimers.

  2011cites this paper
• 3D-pharmacophore model based virtual screening to identify dual-binding site and selective acetylcholinesterase inhibitors

  2011cites this paper
• Multi-target-directed ligands in Alzheimer's disease treatment.

  2011cites this paper
• New Approach in Development of Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease

  2011cites this paper
• Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids?

  2011cites this paper
• Homo- and hetero-dimers of inactive organophosphorous group binding at dual sites of AChE.

  2011cites this paper
• Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods.

  2010cites this paper
• Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.

  2010cites this paper
• Design and Synthesis of Multi Target Compounds for the Treatment of Alzheimer's Disease

  2009cites this paper
• Novel acetylcholinesterase inhibitors: Synthesis and structure–activity relationships of phthalimide alkyloxyphenyl N,N-dimethylcarbamate derivatives

  2009cites this paper
• Design and Synthesis of Multi Target Compounds for the Treatment of Alzheimer’s Disease

  2009cites this paper
• Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects.

  2009cites this paper
• Structure–Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo‐Irreversible Inhibitors Related to Xanthostigmine

  2009cites this paper
• Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's disease.

  2009cites this paper
• Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.

  2008cites this paper
• Design of novel carbamate acetylcholinesterase inhibitors based on the multiple binding sites of acetylcholinesterase

  2008cites this paper
• Catalytic mechanism of l,l-diaminopimelic acid with diaminopimelate epimerase by molecular docking simulations.

  2008cites this paper
• Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease.

  2008cites this paper
• Reaction of N-methyl-5-tributylstannyl-4-fluoro-1H-pyrazole and its application to N-methyl-chromeno[2,3-d]pyrazol-9-one synthesis.

  2008cites this paper
• Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor.

  2007cites this paper
• Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.

  2007cites this paper
• Irinotecan toxicity to human blood cells in vitro: relationship between various biomarkers.

  2007cites this paper
• Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

  2007cites this paper
• Docking and quantum mechanic studies on cholinesterases and their inhibitors.

  2007cites this paper
• Dimeric and hybrid anti-Alzheimer drug candidates.

  2006cites this paper
• Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.

  2005cites this paper
• Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study.

  2005cites this paper
• Xanthone derivatives: new insights in biological activities.

  2005cites this paper
• Synthesis of xanthones: an overview.

  2005cites this paper
• New xanthone derivatives as potent anti-inflammatory agents.

  2005cites this paper
• Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.

  2005cites this paper
• Molecular modelling approaches to the design of acetylcholinesterase inhibitors: new challenges for the treatment of Alzheimer's disease.

  2004cites this paper
• Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics.

  2004cites this paper
• beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

  2003cites this paper
• Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.

  2003cites this paper
• 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.

  2003cites this paper
• Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors.

  2003cites this paper
• Cholinergic toxic syndrome by the anticancer drug irinotecan: Acetylcholinesterase does not play a major role

  2002cites this paper
• Towards improved acetylcholinesterase inhibitors: a structural and computational approach.

  2001cites this paper
• Pharmacological properties of some aminoalkanolic derivatives of xanthone.

  2001cites this paper
• Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan

  2001cites this paper
• Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives.

  2001cites this paper
• A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.

  2001cites this paper
• Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study.

  2001cites this paper
• Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives.

  2000cites this paper
• SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.

  2000cites this paper
• Central selective acetylcholinesterase inhibitor with neurotrophic activity: structure-activity relationships of TAK-147 and related compounds.

  2000cites this paper
• Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.

  1999cites this paper